Fulgent Genetics Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 80c
November 9, 2021 4:28 PM ESTFulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of $4.05, $0.80 better than the analyst estimate of $3.25. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $264 million.
GUIDANCE:
Fulgent Genetics, Inc. sees FY2021 revenue of $930 million, versus the... More



